Neuronetics is trading 6.42% up at $2.40 on October 29, 2026, with healthcare-sector strength a possible supporting factor.
- The healthcare sector was up 2.32%, amid strong results and raised forecasts from major drugmakers.
- No new company-specific announcement explaining the move surfaced in available search results; the company’s latest release schedules third-quarter results for November 4.
- Major U.S. indices were lower, and trading volume was unavailable.